humanitarian
Archived signal
Human medicines European public assessment report (EPAR): Zokovea, ensitrelvir, Date of authorisation: 18/09/2026, Status: Authorised
Human medicines European public assessment report (EPAR): Osenvelt, denosumab, Date of authorisation: 14/02/2025, Revision: 6, Status: Authorised
Reported by EMA What Is New
Read the complete report at EMA What Is New ↗
Verification notice
IntelMap indexes open-source reporting. This page identifies what a source reported; it does not independently confirm the claim.
8 reports · 2 sources
EMA What Is NewHuman medicines European public assessment report (EPAR): Zokovea, ensitrelvir, Date of authorisation: 18/09/2026, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Zokovea, ensitrelvir, Date of authorisation: 18/09/2026, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Tacquell, Autologous melanoma-derived tumor infiltrating lymphocytes, ex vivo-expanded, Date of refusal: 14/09/2026, Stat…EMA What Is NewHuman medicines European public assessment report (EPAR): Tacquell, Autologous melanoma-derived tumor infiltrating lymphocytes, ex vivo-expanded, Date of refusal: 14/09/2026, Stat…EMA What Is NewHuman medicines European public assessment report (EPAR): Yeytuo, lenacapavir, Date of authorisation: 25/08/2025, Revision: 3, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Yeytuo, lenacapavir, Date of authorisation: 25/08/2025, Revision: 3, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Denosumab Ascend, denosumab, Date of authorisation: 28/08/2026, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Denosumab Ascend, denosumab, Date of authorisation: 28/08/2026, Status: Authorised3 recorded states
Signal first indexedP2 · 99% quality · 2 sources
Headline updatedP2 · 99% quality · 2 sources
Source details updatedP2 · 99% quality · 2 sources